Treatment
Heparin clinical trials
We’re tracking 56 recruiting studies that include Heparin, each written for real people, not researchers, below.
Recruiting studies
- NCT07361783Recruiting
Heparin before hospital for heart attack
This trial tests whether giving a blood thinner (heparin) early, before you get to the hospital for a heart attack procedure, can improve outcomes. It is for people having a specific type of heart attack (STEMI) who will receive a balloon angioplasty within 2 hours.
Wuhan, HubeiAges 18 years+ - NCT06869291Enrolling by invitation
Minimally invasive treatment for eyelid cholesterol deposits
This trial tests a new minimally invasive procedure using tiny tunnels and a heparin injection to treat xanthelasma (cholesterol deposits under the skin of the eyelids). It may help reduce the appearance of these deposits with less scarring than traditional methods.
Fuzhou, FujianAges 18–65 - NCT06080074RecruitingPhase 2
Emergency heart-lung machine study for children with severe heart failure
This study tests a specific heart-lung machine called Cardiohelp to help children with severe heart failure. It looks at how well the machine works and whether a blood thinner (either heparin or bivalirudin) is safer and more effective.
Palo Alto, CaliforniaAges birth–16 years - NCT06676085Recruiting
New ECMO blood-thinning strategy with nafamostat
This study tests a new way to manage blood-thinning medicine during ECMO (a machine that helps your heart and lungs). The goal is to see if using a drug called nafamostat in the ECMO circuit along with lower doses of a standard blood thinner can reduce side effects like bleeding.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06329921Enrolling by invitation
Heparin monitoring study at Vanderbilt
This study looks at how well a blood test (PTT) monitors the blood thinner heparin in hospital patients. If you are getting heparin through an IV, this research may help improve how your treatment is managed.
Nashville, TennesseeAges 18 years+ - NCT06575309Recruiting
Blood clotting in pregnancy and the effect of blood thinner
This study looks at how blood clotting changes during pregnancy and how a common blood thinner affects clotting in the lab. It may help doctors understand pregnancy-related clotting risks better.
Clermont-FerrandAges 18–55 - NCT06276010Recruiting
Nafamostat mesilate for blood thinning in ECMO patients
This trial tests a medicine called nafamostat mesilate to prevent blood clots in patients who need ECMO (a machine that helps your heart and lungs) after heart surgery. It may offer a safer way to thin the blood compared to standard treatments.
Beijing, Beijing MunicipalityAges 18 years+ - NCT04861103RecruitingPhase 4
Testing a blood thinner plan during pregnancy
This study looks at how people’s blood and clotting behave during pregnancy when taking a specific blood thinner called low molecular weight heparin (LMWH) three times a day. It may help doctors fine-tune how safely and effectively LMWH is used during pregnancy.
Orange, CaliforniaAges 18 years+ - NCT06275555Recruiting
Bivalirudin for blood thinning in ECMO patients
This trial tests if bivalirudin is a safe and effective blood thinner for people on ECMO, a machine that helps your heart and lungs. You may be eligible if you need this therapy and have no past reactions to similar medicines.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06109155RecruitingPhase 4
Comparing medications to reduce bleeding in heart surgery
This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.
TaichungAges 18 years+ - NCT07477977Recruiting
Finding the right dose of protamine to reverse heparin after heart bypass
This study is testing different doses of a medication called protamine, which is given after heart surgery to reverse the effects of heparin (a blood thinner). The goal is to find the safest and most effective dose for patients who have had a heart-lung bypass machine during surgery.
SohagAges 18 years+ - NCT06583889Recruiting
Endovascular treatment vs standard care for brain blood clot
This trial compares a minimally invasive procedure (endovascular treatment) to standard medical care for a type of blood clot in the brain's veins. It aims to see which approach improves symptoms like headache, vision problems, or seizures.
Beijing, Beijing MunicipalityAges 18–60 - NCT07494877Recruiting
Anticoagulant therapy for infertility in women aged 20-45
This study looks at whether blood-thinning medication can improve the chance of pregnancy in women who have trouble conceiving. It focuses on how the medication affects the lining of the womb and its ability to accept an embryo.
Xi'an, ShaanxiAges 20–45 - NCT05984537RecruitingPhase 4
Bivalirudin during angioplasty for high-risk heart plaques
This study tests whether a blood thinner called bivalirudin, given during a procedure to open blocked heart arteries (PCI), helps blood flow better in the tiny vessels of the heart afterward. It is for people with a recent unstable heart condition and a high-risk plaque seen on a CT scan.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06714864RecruitingPhase 4
Preventing catheter infections in children on dialysis
This study tests a liquid that is put into the dialysis catheter after each session to prevent infections that can happen through the catheter. It is designed for children up to age 18 who need hemodialysis through a catheter.
Birmingham, AlabamaAges Up to 17 years - NCT05701917Recruiting
Clot-busting device versus blood thinners for leg clot
This study compares a clot-removal device (ClotTriever) plus standard care versus standard blood thinners alone for a deep vein clot in the leg. It aims to see which approach better improves leg symptoms and outcomes.
Scottsdale, ArizonaAges 18 years+ - NCT03302195Recruiting
Heparin and bypass blood management for obese heart surgery
This trial studies the best way to manage blood thinning (anticoagulation) during heart surgery that uses a heart-lung machine in people with obesity. It may help reduce blood-clotting and bleeding complications by comparing different care strategies.
Québec, QuebecAges 18 years+ - NCT04049591Recruiting
Higher vs lower heparin dose during planned heart stent procedure
This trial compares a higher versus lower dose of heparin (a blood thinner) during a planned PCI, which is a heart procedure to open blocked arteries using a stent. It may help hospitals and patients know which dosing approach is safest and works well during the procedure.
Hamilton, OntarioAges 18 years+ - NCT04227678Recruiting
Study of how fat is handled after eating in rare LPL deficiency
This study looks at how your body processes fatty acids after meals in people with lipoprotein lipase deficiency (a rare genetic condition). It also compares results to people without the condition, which may help researchers understand metabolism and guide future care.
Sherbrooke, QuebecAges 18–75 - NCT04273607RecruitingPhase 2/Phase 3
Test an ECMO approach without blood thinners for lung failure
This trial studies whether people on a breathing machine called VV-ECMO can be managed without routine blood thinners, to reduce bleeding risk. It is meant for adults with severe lung failure (ARDS) and checks that it is safe for you to avoid anticoagulation.
Toronto, OntarioAges 18 years+ - NCT04918524Recruiting
Pregnancy outcomes in women with certain autoimmune conditions
This study looks at the typical pregnancy course and outcomes for women with APS or UCTD, two autoimmune-related conditions. It also checks how these conditions and treatments may affect pregnancy, so doctors can better plan care.
Jinan, ShandongAges 20–45 - NCT05117125Recruiting
Testing for markers in early ventilator lung infections
This study looks at changes (biomarkers) in the blood or other samples from people on a breathing machine. It may help doctors detect ventilator-associated pneumonia earlier and tailor treatment sooner.
DrammenAges 18 years+ - NCT05498428RecruitingPhase 2
Amivantamab for advanced lung cancer with EGFR mutations
This Phase 2 study tests amivantamab (an antibody medicine) in people with advanced or metastatic non-small cell lung cancer that has specific EGFR gene changes. It may help shrink tumors or control cancer when standard curative treatments aren’t possible.
La Jolla, CaliforniaAges 18 years+ - NCT05848713RecruitingPhase 3
Blood-thinner treatment for complications of community pneumonia
This Phase 3 trial tests whether an anti-clot “blood thinner” can reduce complications from community-acquired pneumonia in hospitalized adults who need extra oxygen. It may help by lowering harmful clot-related effects during serious lung infection.
Chicago, IllinoisAges 18 years+
Common questions
- Are there clinical trials studying Heparin?
- Yes. Clin2 currently lists 56 recruiting studies that include Heparin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Heparin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Heparin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Heparin or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.